Refuge Biotechnologies Picks Up $25M
Menlo Park-based Refuge Biotechnologies, which is developing cell therapies for oncology, said on Wednesday it has raised $25M in a Series B funding round. The funding was led by 3SBio and Sequoia China, and also included Danhua Capital (DHVC), Sangel Capital and Ocean Pine Healthcare Fund, plus, 3E Bioventures, WuXi Healthcare Ventures, and ShangBay Capital.
posted on Thursday, May 3, 2018 (Link to more information)
Related companies:
Refuge Biotech
Related stories:
> Amyris Biotechnologies Gets $24.75M
> Microchip Biotechnologies Gains $18.1M
> Amyris Biotechnologies Raises $70M
> Amyris Biotechnologies Gets $41.75M
> Microchip Biotechnologies Raises $4.5M
silicontap.com Home